Reduction of prefrontal gray matter volume in first-episode schizophrenia independent of risperidon treatment

KAŠPÁREK, Tomáš, Radovan PŘIKRYL, Daniel SCHWARZ, Hana KUČEROVÁ, Michal MIKL, Eva ČEŠKOVÁ and Petr KRUPA. Reduction of prefrontal gray matter volume in first-episode schizophrenia independent of risperidon treatment. The International Journal of Neuropsychopharmacology. Cambridge, U.K.: Cambridge University Press, 2006, suppl. 1, No 9, p. 224. ISSN 1461-1457.

Basic information

• Original name: Reduction of prefrontal gray matter volume in first-episode schizophrenia independent of risperidon treatment
• Name in Czech: Redukce prefrontální šedé kůry mozkové u první epizody schizofrenie a souvislost léčbou risperidonem.
• Name (in English): Reduction of prefrontal gray matter volume in first-episode schizophrenia independent of risperidon treatment
• Authors: KAŠPÁREK, Tomáš (203 Czech Republic), Radovan PŘIKRYL (203 Czech Republic), Daniel SCHWARZ (203 Czech Republic), Hana KUČEROVÁ (203 Czech Republic), Michal MIKL (203 Czech Republic), Eva ČEŠKOVÁ (203 Czech Republic, guarantor) and Petr KRUPA (203 Czech Republic).
• Edition: The International Journal of Neuropsychopharmacology, Cambridge, U.K. Cambridge University Press, 2006, 1461-1457.

Other information

• Original language: Czech
• Type of outcome: Article in a journal
• Field of Study: 30000 3. Medical and Health Sciences
• Country of publisher: Czech Republic
• Confidentiality degree: is not subject to a state or trade secret
• Impact factor: Impact factor: 5.184
• RIV identification code: RIV/00216224:14110/06:00017087
• Organization unit: Faculty of Medicine
• UT WoS: 000240771300244
• Keywords in English: schizophrenia; gray matter; risperidone
• Tags: gray matter, risperidone, schizophrenia

Abstract

In a group of first-episode schizophrenia patients gray matter reduction in prefrontal areas did not correlate with risperidone treatment parameters (cummulative dose, duration of treatment in days). The GM changes in these areas cannot be ascribed to the influence of the treatment with antipsychotics.

Abstract (in English)

In a group of first-episode schizophrenia patients gray matter reduction in prefrontal areas did not correlate with risperidone treatment parameters (cummulative dose, duration of treatment in days). The GM changes in these areas cannot be ascribed to the influence of the treatment with antipsychotics.

Links

• MSM0021622404, plan (intention): Name: Vnitřní organizace a neurobiologické mechanismy funkčních systémů CNS

Investor: Ministry of Education, Youth and Sports of the CR, The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions.